A Frontier Company in Personalized Medicine

We aim to become a frontier company in personalized medicine. By applying the latest high throughput genomic analysis technologies, we have successfully analyzed wide-ranging samples derived not only from human but also from an extensive list of plant and animal species. As a result, we have become one of the most longstanding company that maintains high-quality genetic data deliveries, and expertise in analyzing and interpreting them. We also remain to be the frontier company that combines biotechnology and information technology by developing bioinformatics  workflow, with which we established genetic information databases to identify the genetic characteristics of populations, integrated genetic analysis to discover genomic biomarkers, and carried out analysis combining genetic and clinical data. We thrive to contribute to the public health and well-being by leading major-scale personalized medical projects, partnering with research institutes not only in Korea but also from all over the world.

JS Link will continue to provide breakthrough for challenging R&D projects, aiming to bring advancement to the cure rate of diseases along with customized treatments that enable disease prevention and early diagnosis accordingly to genetic differences.